Lithium Treatment in Affective Disorders
نویسندگان
چکیده
50 manic patients of unipolar and bipolar affective illness were placed on oral lithium 600-1500 mg daily and serum levels in the range of 0.49-1.23 mEq/L. A better response in bipolar disorders than unipolar was observed. Besides, a much better response to lithium therapy is observed in patients with disease of longer duration and a positive history of affective illness in blood relations. Therapeutic effect had no relationship in terms of age or sex of the patients.
منابع مشابه
Managing the risk of lithium-induced nephropathy in the long-term treatment of patients with recurrent affective disorders
Lithium has been the most effective psychopharmacological drug in the long-term treatment of patients with recurrent unipolar and bipolar affective illness. As a result of its widespread and longtime use in patients with recurrent affective disorders, psychiatrists have become increasingly aware of the whole spectrum of lithium's potential side effects. One of the side effects associated with i...
متن کاملLower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis.
OBJECTIVE To compare suicide rates with vs. without long-term lithium treatment in major affective disorders. METHOD Broad searching yielded 22 studies providing suicide rates during lithium maintenance; 13 also provide rates without such treatment. Study quality was scored, between-study variance tested, and suicide rates on vs. off lithium examined by meta-analyses using random-effects regr...
متن کاملLithium in bipolar and other affective disorders: prescribing practice in the UK.
The use of lithium for the treatment of mania, prophylaxis of bipolar disorder and augmentation of antidepressants in treatment-refractory unipolar depression is supported by British Association for Psychopharmacology and National Institute for Health and Clinical Excellence guidelines. We describe prescribing patterns with lithium in a large sample of patients with affective disorders. Data we...
متن کاملThe comparative efficacy of carbamazepine low and high serum level and lithium carbonate in the prophylaxis of affective disorders.
The prophylactic efficacy of carbamazepine slow release (CBZ) at ke different blood levels and lithium carbonate slow release (LI) was compared in a retrospective/prospective, randomized, 2-year open trial. 84 patients with a DSM-III-R diagnosis of recurrent affective disorder who had no prophylactic medication in the 2 years preceding the trial (no LI nonresponders), were randomly allocated to...
متن کاملLong-term lithium treatment and thyroid antibodies: a controlled study.
OBJECTIVE Because the role of thyroid autoimmunity in the development of lithium-induced thyroid dysfunction remains controversial, we compared the prevalence of thyroid autoantibodies in patients with affective disorders receiving long-term lithium maintenance therapy with that of age- and sex-matched controls. METHODS We conducted a cross-sectional study with 100 adult patients with major a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 23 شماره
صفحات -
تاریخ انتشار 1981